Vireo Healthtech Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 69.37 Cr
as on 28-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 60.00 Cr
as on 28-12-2024
- Revenue 135.55%
(FY 2021)
- Profit -1741.88%
(FY 2021)
- Ebitda 9.08%
(FY 2021)
- Net Worth -359.36%
(FY 2021)
- Total Assets -95.30%
(FY 2021)
About Vireo Healthtech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 70.00 Cr and a paid-up capital of Rs 69.37 Cr.
The company has closed loans amounting to ₹60.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vireo Healthtech Private Limited India is Surbhi Jain as COMPANY SECRETARY. Nandita Swamy and Girish Rao serve as directors at the Company.
- CIN/LLPIN
U85110KA2014PTC073627
- Company No.
073627
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2014
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vireo Healthtech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surbhi Jain | Company Secretary | 10-Apr-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Rao  | Director | 26-Feb-2020 | Current |
| Nandita Swamy | Director | 04-Dec-2014 | Current |
Financial Performance of Vireo Healthtech.
Vidal Health Best Doctors Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 135.55% increase. The company also saw a substantial fall in profitability, with a 1741.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 359.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vireo Healthtech?
In 2021, Vireo Healthtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vidal Healthcare Services Private LimitedActive 14 years 4 monthsNandita Swamy and Girish Rao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jun 2023 | ₹60.00 Cr | Satisfied |
How Many Employees Work at Vireo Healthtech?
Unlock and access historical data on people associated with Vireo Healthtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vireo Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vireo Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
